Search

everythinglearnresearchcommunity

for

Search:↓

Treating chronic hand eczema costs about the same in statutory and occupational health insurances in Germany, but work-related cases may lead to higher indirect costs due to longer work absences.

Treating psoriasis with UVB light three times a week is faster than twice a week, and certain medications and lifestyle factors affect psoriasis treatment outcomes.

Treating hematospermia can improve sexual function and reduce anxiety.

Treating underlying metabolic and hormonal issues is key to managing female hair loss.

Low-dose oral minoxidil is effective and safe for treating hair loss in men and women.

Practitioners treating hair loss need better education and resources to overcome challenges like commercial bias and ethical dilemmas.

When treating older patients with both heart valve disease and heart muscle disease, doctors should create personalized treatment plans that address both conditions.

Before treating hair loss, it's crucial to diagnose and treat any underlying medical conditions that may be causing it.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Zinc is effective for treating various skin conditions, including warts and acne.

Baricitinib was effective in treating alopecia areata in two major trials.

Spironolactone is effective in treating excessive hair growth in women.

Microneedling is promising for treating various skin issues but needs more research to confirm its effectiveness and safety.

Spironolactone is effective for treating acne, hirsutism, and androgenic alopecia in women with few side effects.

PRP shows potential for treating female hair loss, but more research needed.

Cyclosporin is effective in treating dog skin diseases and has fewer side effects compared to other treatments.

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.

Neurosteroids show promise for treating epilepsy and more research is needed.

Cyclosporin is effective for treating skin conditions in small animals, but requires careful dosing and monitoring for side effects.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

DPCP is effective for treating severe alopecia areata, but relapse is common.

Itraconazole was effective in treating unusual M. canis infections in only one of two HIV-infected men.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

New skin substitutes for treating severe burns and chronic wounds are being developed, but a permanent solution for deep wounds is not yet available commercially.